NCT07624331 Volumetric Analysis of Peri-Implant Soft Tissue Changes Between Polyethereketone(PEEK) Anatomic Healing Abutments and Standard Healing Abutments in Posterior Single Implant Restorations
| NCT ID | NCT07624331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | DR NUR HAFIZAH KAMAR AFFENDI |
| Condition | Peri-Implant Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2026-05-23 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2026-05-23 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized clinical trial will evaluate the clinical outcomes of the implant crown fabricated with standard scan body (control) and polyetheretherketone (PEEK) anatomic healing abutment (test).
Eligibility Criteria
Inclusion Criteria: legally competent to provide written informed consent form prior to any study related procedures. * Subjects of either sex or aged 18 above * requires replacement of a single missing posterior tooth with adequate mesiodistal dimension (≥8 mm) * intact adjacent teeth on both sides with existing opposing tooth condition * good oral hygiene, plaque score \<25% bpe1 * adequate keratinized mucosa width (kmw) minimum 6 mm at the edentulous site * adequate bone volume to accommodate the planned dental implant placement of 5.5 mm diameter and 10 mm in length as verifified by Cone Beam Computed Tomography (CBCT) * adequate interoccusal distance (crown height space) of at least 6mm measured from alveolar crest to the occlusal table. Exclusion Criteria: Localized or generalized periodontitis * Presence of active acute infection * History of malignancy, radiotherapy or chemotherapy * Bone metabolic diseases (e.g.: osteogenesis imperfecta, Paget's disease) or current use of medications affecting bone metabolism * Untreated bruxism or parafunctional habits Docusign Envelope ID: FFD7C6C1-66CB-4359-9662-63230F769528 22 * Severe occlusal discrepancy * Any medical condition contraindicating implant placement or alter daily activities to a level consistent with ASA (American Society of Anesthesiologist) III classification (including cardiovascular, hepatic, renal, gastrointestinal, metabolic, neurologic, pulmonary, endocrine, autoimmune or psychiatric disorders) * Subjects in need of bone grafting at the site of intended implantation site. * Subjects that are pregnant
Contact & Investigator
Professor Dr Mohd Yusmiaidil Putera Mohd Yusoff, phd
STUDY DIRECTOR
Universiti Teknologi Mara
Frequently Asked Questions
Who can join the NCT07624331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peri-Implant Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07624331 currently recruiting?
Yes, NCT07624331 is actively recruiting participants. Contact the research team at hafizah_kamar@uitm.edu.my for enrollment information.
Where is the NCT07624331 trial being conducted?
This trial is being conducted at Sungai Buloh, Malaysia.
Who is sponsoring the NCT07624331 clinical trial?
NCT07624331 is sponsored by DR NUR HAFIZAH KAMAR AFFENDI. The principal investigator is Professor Dr Mohd Yusmiaidil Putera Mohd Yusoff, phd at Universiti Teknologi Mara. The trial plans to enroll 38 participants.